Invention Grant
- Patent Title: Potassium channel inhibitors
-
Application No.: US18239348Application Date: 2023-08-29
-
Publication No.: US11945811B2Publication Date: 2024-04-02
- Inventor: Antonio Mete , Ulrik Sørensen
- Applicant: ACESION PHARMA APS
- Applicant Address: DK Copenhagen N
- Assignee: ACESION PHARMA APS
- Current Assignee: ACESION PHARMA APS
- Current Assignee Address: DK Copenhagen N
- Agency: Maier & Maier, PLLC
- Priority: EP 164078.4 2021.03.22
- Main IPC: C07D413/12
- IPC: C07D413/12 ; C07D401/12 ; C07D403/06 ; C07D403/12 ; C07D413/06 ; C07D417/06

Abstract:
A compound of the general formula (I), and the pharmaceutical composition including a compound of formula (I) and optionally a pharmaceutically acceptable additive. Also, the treatment of a cardiac disease, disorder or condition in a mammal, which includes the administration to the mammal a therapeutically effective amount of at least one compound of formula (I), or the pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20230406845A1 NOVEL POTASSIUM CHANNEL INHIBITORS Public/Granted day:2023-12-21
Information query